tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Daina Graybosch, 93 are a BUY (81.58%), 21 are a HOLD (18.42%).
Analyst Daina Graybosch, currently employed at LEERINK, carries an average stock price target met ratio of 44.78% that have a potential upside of 30.67% achieved within 258 days.
Daina Graybosch’s has documented 198 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ITOS, Iteos Therapeutics at 14-May-2025.
Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for SBTX (SILVERBACK THERAPEUTICS ) at 12/29/2020. The price target of $40 was fulfilled within 1 day with a profit of $3 (8.11%) receiving and performance score of 81.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$115
$49.65 (75.98%)
$115
12 days ago
(16-Jun-2025)
9/11 (81.82%)
$50.91 (79.44%)
104
Buy
$93
$27.65 (42.31%)
$82
1 months 19 days ago
(09-May-2025)
2/3 (66.67%)
$35.45 (61.60%)
126
Buy
$105
$39.65 (60.67%)
$96
6 months 18 days ago
(10-Dec-2024)
17/18 (94.44%)
$22.73 (27.63%)
81
Buy
$114
$48.65 (74.45%)
$77
6 months 18 days ago
(10-Dec-2024)
2/3 (66.67%)
$31.73 (38.57%)
33
Buy
$112
$46.65 (71.38%)
$100
6 months 19 days ago
(09-Dec-2024)
4/5 (80%)
$29.05 (35.02%)
106
Which stock is Daina Graybosch is most bullish on?
Which stock is Daina Graybosch is most reserved on?
What Year was the first public recommendation made by Daina Graybosch?
